| Net (loss) | -5.71M |
| Stock based compensation | 60.08K |
| Depreciation, depletion, amortization and accretion | 0 |
| Gain (loss) on sale of marketable securities | 0 |
| Loss on equity method investment | |
| Loss on abandonment | |
| Non cash interest expense incurred in connection with debt restructure and debt forgiveness | 0 |
| Gain on debt forgiveness | |
| Receivables | |
| Prepaid expenses and other assets | 28.59K |
| Accounts payable and accrued expenses | 2.84M |
| Due from related party | |
| Net cash (used in) operating activities | -148.76K |
| Proceeds from sale of marketable securities | 0 |
| Restricted cash | |
| Net cash provided by investing activities | 0 |
| Proceeds from related party borrowings | 99.1K |
| Net cash provided by financing activities | 99.1K |
| Net increase (decrease) in cash and cash equivalents | -49.67K |
| Cash and cash equivalents, beginning of period | 61.02K |
| Cash and cash equivalents, end of period | 11.35K |
| Cash paid for interest | 0 |